Search results for: Health Care Systems
Filter search results
The Tougher the Better: The Effect of GP Performance Thresholds in Scotland
20 April 2012
…that the QOF achievement has had a negligible impact on health outcomes. The OHE’s Yan Feng and her colleagues take a closer look at the effect of changes in the…
Can and Should Value Based Pricing Be Applied to Molecular Diagnostics?
1 May 2012
…affect their health in future. Current pricing and reimbursement systems for diagnostics, however, are not efficient and provide poor incentives for new diagnostic approaches. Prices often are driven by administrative…
OHE Models Future UK Medicines Spending for the ABPI
3 July 2012
The Office of Health Economics has developed and run a model for the ABPI to project UK NHS expenditure on medicines. On 2 July, the ABPI released its projections for…
OHE Conference on the Future of Drug Development – Register Now
5 September 2012
…of UK and EU regulatory agencies, the pharmaceutical industry and payers — as well as leading experts in health technology assessment, pricing and reimbursement, and R&D structure and incentives. Among…
OHE Study on Pharmaceutical R&D Costs Released
3 December 2012
…the long-term investments involved. The Office of Health Economics today released a comprehensive study of the cost of R&D for new medicines. How much it costs to research and develop…
New Findings: Public Attitudes Towards End-of-Life Treatment in England and Wales
7 December 2012
In 2009, the UK’s National Institute for Health and Clinical Excellence (NICE) issued supplementary advice that its Appraisal Committees are to consider when assessing treatments that extend life at the…
Spotlight on OHE: Value Based Pricing and New Technologies
31 December 2012
…also included how VBP might treat medicines with multiple indications of different “value”. Emerging Picture of Value Based Pricing from Office of Health Economics Adrian Towse was invited by…
David McKinney
6 May 2026
…antimicrobial resistance impacts health systems more widely, including its implications for areas like cancer treatment, helping translate complex evidence into actionable policy decisions. Prior to founding ARMoR, he spent five…
Shalu Jain
29 June 2023
…of Health Research (DHR), MOHFW, New Delhi, India as Scientist-C and played a key role in establishing Health Technology Assessment in India (HTAIn), a unit within the health ministry to…